☰

Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods

https://onlinelibrary.wiley.com/doi/10.1002/pds.5439 

Katie A. Sharff, David M. Dancoes, Jodi L. Longueil, Eric S. Johnson, and Paul F. Lewis
April 11, 2022
Pharmcoepidemiology & Drug Safety
Kaiser Permanente Northwest

© 2022 John Wiley & Sons Ltd.

document
adverse events,COVID-19,heart disorders,mRNA,vaccines